Arno Therapeutics, Inc. announced that it has expanded its management team with the appointment of Lawrence A. Kenyon as Chief Financial Officer. Mr. Kenyon will report to President and Chief Executive Officer Glenn Mattes, and will direct financial reporting and controls. Mr. Kenyon joins Arno with 25 years of senior-level finance and accounting experience.

Most recently, he was Interim President and CEO, CFO and Corporate Secretary at Tamir Biotechnology, Inc.